2026-02-24
Grip Strength as a Longevity Biomarker: Evidence and Interventions
Grip strength is one of the most powerful and accessible biomarkers of biological aging, predicting cardiovascular events, hospitalization, and all-cause mortality more reliably than many clinical tests. This article covers the mechanisms, evidence, and interventions.
2026-02-24
Grip Strength as a Longevity Biomarker: What It Predicts and How to Maintain It
Grip strength is a validated predictor of all-cause mortality, cardiovascular outcomes, and functional decline. This review covers the evidence base, what thresholds matter, and practical strategies to maintain grip and overall muscular capacity with age.
2026-02-24
Post-Hospitalization Recovery: Reversing Deconditioning and Preventing Long-Term Frailty
Hospitalization is a major driver of functional decline in older adults. Even short stays cause substantial muscle loss and reduce independence. This article covers the evidence for rapid, structured recovery with early mobilization and targeted nutritional support.
2026-02-24
Senolytics and Cellular Senescence: Mechanisms, Mayo Clinic Evidence, and Clinical Status
Senolytics are drugs and compounds that selectively clear senescent cells, which accumulate with age and drive chronic inflammation. This review covers the mechanisms, the Mayo Clinic dasatinib+quercetin trials, fisetin evidence, and the current clinical status.
2026-02-24
Vestibular Dysfunction in Aging: Dizziness, Balance, and Rehabilitation Evidence
Age-related vestibular decline affects over 35% of adults over 40 and is a leading cause of falls. Vestibular rehabilitation therapy has strong RCT evidence for reducing dizziness burden and improving gait confidence in peripheral vestibular hypofunction. Early diagnosis and structured rehabilitation significantly alter trajectory.